Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 61 - 70 of 106

Selected Filters:
7 July 2022

Oral PrEP Re-initiation Standard Operating Procedures

Oral pre-exposure prophylaxis (PrEP) clients may choose to stop and restart oral PrEP due to factors such as changes in perceived personal exposure to HIV, the behaviors of a sexual or injecting drug partner, the burden of taking a daily pill, side effects, and mobility. Oral PrEP programs should counsel patients on how to safely…

Community/Advocacy, Demand Creation/Marketing

Document
7 July 2022

Healthcare Worker Guide to Providing PrEP

Calling all healthcare providers! This video is for you, as we outline some top tips and guidance on prescribing PrEP. We want to empower you with the information you need about PrEP, inform you on how best to counsel your client on what’s right for them, and support them in a non-judgmental manner. This is…

Community/Advocacy, Demand Creation/Marketing

External Link
7 July 2022

The Years Ahead in Biomedical HIV Prevention Research

This graphic shows the updated status of large-scale prevention trials through 2024.

Community/Advocacy

External Link
7 July 2022

Pre-Exposure Prophylaxis: An introductory factsheet

This introductory 2-page document defines PrEP, reviews the scientific evidence to date, and outlines key research, regulatory and advocacy issues going forward. This factsheet is part of a series on emerging HIV prevention strategies.

Community/Advocacy

External Link
7 July 2022

DISCOVER Trial Factsheet

This factsheet provides details on the DISCOVER trial to assess whether F/TAF (trade name Descovy) is as safe and effective as an oral daily HIV pre-exposure prophylaxis (PrEP) product.

Community/Advocacy, Research

External Link
7 July 2022

Ring Backgrounder

What is the dapivirine ring? How does it work? Is it safe to use? These are all questions that this Dapivirine Ring backgrounder by the International Partnership for Microbicides (IPM) answers.

Community/Advocacy

External Link
7 July 2022

WHO recommends the Dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

This article announces the WHO's recommendation that the dapivirine vaginal ring may be offered as an additional prevention choice for women at substantial risk of HIV infection as part of combination prevention approaches.

Community/Advocacy, Normative Guidance/Policies

External Link
7 July 2022

Dapivirine Ring Advocacy Messaging Resource Package

The Dapivirine Vaginal Ring Advocacy Messaging Resource Package is a set of resources geared toward developing a messaging framework and implementation plan in support of PrEP Ring advocacy activities. Resources include the complete manual, the advocacy messaging framework template, FAQs, Ambassador toolkits, and a slide deck about the PrEP Ring.

Community/Advocacy, Demand Creation/Marketing

Document
7 July 2022

Put a ring on it: Four reasons to make the Dapivirine ring an HIV prevention option for women and girls

This article explains how the dapivirine vaginal ring can put the power of prevention directly in women's hands.

Community/Advocacy, Demand Creation/Marketing

External Link
7 July 2022

What Young Women Want

This letter comes from a group of young African women and reflects their HIV prevention research priorities. It was submitted to the National Institutes of Health’s (NIH) Division of AIDS (DAIDS) during the open-comment period concerning the structure and agenda for its next funding cycle (2021-2027).

Community/Advocacy

External Link